Get started
MedincellMedincellMedincell

Medincell

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪964.72 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.71 USD
Net income (FY)
‪−19.95 M‬ USD
Revenue (FY)
‪27.50 M‬ USD
Shares float
‪29.29 M‬
Beta (1Y)
1.50

Employees


Employees (FY)
140
Change (1Y)
+6 +4.48%
Revenue / Employee (1Y)
‪196.43 K‬ USD
Net income / Employee (1Y)
‪−142.48 K‬ USD

About MedinCell SA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Christophe Douat
Website
medincell.com
Headquarters
Jacou
Founded
2003
IPO date
Oct 8, 2018
Identifiers
2
ISIN FR0004065605
MedinCell SA is a pharmaceutical company, which engages in the development of injectable products in therapeutic areas. It focuses on combining its proprietary BEPO technology with active ingredients already known and marketed; it controls the regular delivery of a drug at the optimal therapeutic dose. The company was founded by Anh Nguyen and Christophe Douat on January 9, 2003 and is headquartered in Jacou, France.

Check out other big names from the same industry as MDCLF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight
0.03%
Market value
‪1.09 M‬
USD
CSEMUS.EUR
iShares MSCI EMU Small Cap UCITS ETF
Weight
0.08%
Market value
‪1.03 M‬
USD
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- Capitalisation
Weight
0.07%
Market value
‪636.05 K‬
USD
EMUSCD.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR Ukdis- Distribution
Weight
0.07%
Market value
‪636.05 K‬
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- Distribution
Weight
0.07%
Market value
‪636.05 K‬
USD
SMC
SPDR MSCI Europe Small Cap UCITS ETF (Ireland)
Weight
0.03%
Market value
‪109.65 K‬
USD
IEUS
iShares MSCI Europe Small-Cap ETF
Weight
0.03%
Market value
‪50.20 K‬
USD
IBRN
iShares Neuroscience and Healthcare ETF
Weight
0.82%
Market value
‪38.98 K‬
USD
DBEZ
Xtrackers MSCI Eurozone Hedged Equity ETF
Weight
0.01%
Market value
‪5.09 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of MDCLF is 34.39 USD — it has increased by 393.00% in the past 24 hours. Watch Medincell stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Medincell stocks are traded under the ticker MDCLF.
We've gathered analysts' opinions on Medincell future price: according to them, MDCLF price has a max estimate of 59.76 USD and a min estimate of 35.26 USD. Watch MDCLF chart and read a more detailed Medincell stock forecast: see what analysts think of Medincell and suggest that you do with its stocks.
MDCLF reached its all-time high on Jan 23, 2026 with the price of 34.39 USD, and its all-time low was 6.97 USD and was reached on Jul 31, 2023. View more price dynamics on MDCLF chart.
See other stocks reaching their highest and lowest prices.
MDCLF stock is 79.72% volatile and has beta coefficient of 1.50. Track Medincell stock price on the chart and check out the list of the most volatile stocks — is Medincell there?
Today Medincell has the market capitalization of ‪964.84 M‬, it has increased by 6.26% over the last week.
Yes, you can track Medincell financials in yearly and quarterly reports right on TradingView.
Medincell is going to release the next earnings report on Jun 10, 2026. Keep track of upcoming events with our Earnings Calendar.
MDCLF earnings for the last half-year are −0.57 USD per share, whereas the estimation was −0.31 USD, resulting in a −88.46% surprise. The estimated earnings for the next half-year are −0.26 USD per share. See more details about Medincell earnings.
Medincell revenue for the last half-year amounts to ‪13.62 M‬ USD, despite the estimated figure of ‪11.08 M‬ USD. In the next half-year revenue is expected to reach ‪18.84 M‬ USD.
MDCLF net income for the last half-year is ‪−18.87 M‬ USD, while the previous report showed ‪−4.19 M‬ USD of net income which accounts for −350.62% change. Track more Medincell financial stats to get the full picture.
No, MDCLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 140 employees. See our rating of the largest employees — is Medincell on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medincell EBITDA is ‪−13.89 M‬ USD, and current EBITDA margin is −44.09%. See more stats in Medincell financial statements.
Like other stocks, MDCLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medincell stock right from TradingView charts — choose your broker and connect to your account.